Item 5.02 Departure of Directors or Certain Officers; Election of Directors;


          Appointment of Certain Officers; Compensatory Arrangements of Certain
          Officers.

On March 12, 2020, our Board of Directors approved 2020 corporate goals under our annual performance-based bonus program. The 2020 corporate goals consist of financial goals, including budgeting, cash runway and compliance goals (weighted at 30%), project-based goals, including clinical development and progress with respect to the potential pivotal ENVASARC clinical study, quality assurance, and regulatory goals (weighted at 60%), and business development goals, consisting of in-licensing or partnering goals (weighted at 10%). After the end of the year, our Board of Directors will assess our achievement against the corporate goals, as well as each executive officer's individual contributions towards reaching the corporate goals, in determining awards to our executive officers under our annual performance-based bonus program.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses